Krzysztof Kurcon

Krzysztof Kurcon has extensive work experience in the field of clinical research and pharmaceuticals. Starting in 2003, they worked as a Medical Representative at Aventis Pharma for a year. In 2007, they joined Boston Scientific as a Field CRA before transitioning to Novate Medical Limited in 2011, where they served as the only representative of the company in Poland and was responsible for all activities related to clinical trials. Krzysztof then joined Portola Pharmaceuticals in 2013 as a Clinical Trial Liaison, eventually becoming a Senior Manager in that role. In 2015, they joined Medtronic as a Senior Field Monitor. Subsequently, they worked as a Clinical Enrollment Specialist at both Innovative Trials and CSSi - Global Patient Recruitment starting in 2016. In 2017, they joined Boston Scientific again as a CRA, focusing on Neuromodulation projects. In 2019, they became the Country Manager at Confidence Pharmaceutical Research. Finally, in 2018, they became the CEO of CLINBIT.

From 1992 to 1997, Krzysztof Kurcon attended Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie. No specific degree or field of study was mentioned in the information provided.